TransMedics Group, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
TransMedics Group, Inc. (TMDX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 758.57 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 758.57K shares, a 20.87% increase year-over-year.
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 5.04M shares, a 354.00% increase year-over-year.
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 329.46K shares, a 93.34% decline year-over-year.
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 627.59K shares, a 88.08% decline year-over-year.
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 545.68K shares, a 89.68% decline from fiscal 2024.
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.29M shares, a 10.84% decline from fiscal 2023.
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.93M shares, a 75.27% increase from fiscal 2022.
- TransMedics Group, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.38M shares, a 17.69% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 758.57K shares 10-Q · filed 2026-08-04 | 5.35M shares 10-Q · filed 2026-08-04 | ||||||
| 2026-03-31 | 5.04M shares 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 545.68K shares 10-K · filed 2026-02-24 | |||||||
| 2025-09-30 | 329.46K shares 10-Q · filed 2025-10-29 | 685.96K shares 10-Q · filed 2025-10-29 | ||||||
| 2025-06-30 | 627.59K shares 10-Q · filed 2026-08-04 | 867.16K shares 10-Q · filed 2026-08-04 | ||||||
| 2025-03-31 | 1.11M shares 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | 5.29M shares 10-K · filed 2026-02-24 | |||||||
| 2024-09-30 | 4.95M shares 10-Q · filed 2025-10-29 | 5.24M shares 10-Q · filed 2025-10-29 | ||||||
| 2024-06-30 | 5.26M shares 10-Q · filed 2025-07-30 | 5.38M shares 10-Q · filed 2025-07-30 | ||||||
| 2024-03-31 | 5.50M shares 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 5.93M shares 10-K · filed 2026-02-24 | 8.54M shares 10-K · filed 2024-02-27 | ||||||
| 2023-09-30 | 8.38M shares 10-Q · filed 2024-10-29 | 6.00M shares 10-Q · filed 2024-10-29 | 8.41M shares 10-Q · filed 2023-11-08 | |||||
| 2023-06-30 | 6.17M shares 10-Q · filed 2024-08-01 | 4.80M shares 10-Q · filed 2024-08-01 | 8.38M shares 10-Q · filed 2023-08-04 | |||||
| 2023-03-31 | 3.43M shares 10-Q · filed 2024-05-02 | 3.40M shares 10-Q · filed 2023-05-04 | ||||||
| 2022-12-31 | 3.38M shares 10-K · filed 2025-02-27 | 3.34M shares 10-K · filed 2023-02-27 | ||||||
| 2022-09-30 | 3.41M shares 10-Q · filed 2023-11-08 | |||||||
| 2022-06-30 | 3.58M shares 10-Q · filed 2023-08-04 | |||||||
| 2022-03-31 | 3.56M shares 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | 2.87M shares 10-K · filed 2023-02-27 | |||||||
| 2021-09-30 | 2.83M shares 10-Q · filed 2022-11-04 | |||||||
| 2021-06-30 | 2.79M shares 10-Q · filed 2022-08-03 | |||||||
| 2021-03-31 | 2.84M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 2.34M shares 10-K · filed 2022-03-01 | |||||||
| 2020-09-30 | 2.33M shares 10-Q · filed 2021-11-09 | |||||||
| 2020-06-30 | 2.33M shares 10-Q · filed 2021-08-06 | |||||||
| 2020-03-31 | 2.25M shares 10-Q · filed 2021-05-07 | |||||||
| 2019-12-28 | 2.02M shares 10-K · filed 2021-03-11 | |||||||
| 2019-09-28 | 2.03M shares 10-Q · filed 2019-11-08 | |||||||
| 2019-06-29 | 2.08M shares 10-Q · filed 2020-08-07 | |||||||
| 2019-03-30 | 14.78M shares 10-Q · filed 2020-05-06 | |||||||
| 2018-12-29 | 14.81M shares 10-K · filed 2020-03-17 | |||||||
| 2018-09-29 | 14.72M shares 10-Q · filed 2019-11-08 | |||||||
| 2018-06-30 | 14.74M shares 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 14.74M shares 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |